283 related articles for article (PubMed ID: 26473738)
1. Decreased VEGF Level Is Associated with Elevated Ferritin Concentration in Bronchoalveolar Lavage Fluid of Children with Interstitial Lung Diseases.
Papp Á; Bene Z; Gáspár I; Nagy B; Kádár L; Márialigeti T; Bánfi A; Baktai G; Balla G; Nagy B
Respiration; 2015; 90(6):443-450. PubMed ID: 26473738
[TBL] [Abstract][Full Text] [Related]
2. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
3. Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease.
Sakamoto N; Ishimoto H; Kakugawa T; Satoh M; Hasegawa T; Tanaka S; Hara A; Nakashima S; Yura H; Miyamura T; Koyama H; Morita T; Nakamichi S; Obase Y; Ishimatsu Y; Mukae H
BMC Pulm Med; 2018 Mar; 18(1):44. PubMed ID: 29530007
[TBL] [Abstract][Full Text] [Related]
4. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
6. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis.
Yamanouchi H; Fujita J; Yoshinouchi T; Hojo S; Kamei T; Yamadori I; Ohtsuki Y; Ueda N; Takahara J
Respir Med; 1998 Feb; 92(2):273-8. PubMed ID: 9616525
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
Meyer KC; Cardoni A; Xiang ZZ
J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049
[TBL] [Abstract][Full Text] [Related]
8. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
9. A vascular endothelial growth factor deficiency characterises scleroderma lung disease.
De Santis M; Bosello SL; Capoluongo E; Inzitari R; Peluso G; Lulli P; Zizzo G; Bocci M; Tolusso B; Zuppi C; Castagnola M; Ferraccioli G
Ann Rheum Dis; 2012 Sep; 71(9):1461-5. PubMed ID: 22402140
[TBL] [Abstract][Full Text] [Related]
10. The characteristics and clinical significance of mucin levels in bronchoalveolar lavage fluid of patients with interstitial lung disease.
Wei L; Zhao J; Bao J; Ma Y; Shang Y; Gao Z
J Investig Med; 2019 Apr; 67(4):761-766. PubMed ID: 30573494
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
12. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
[TBL] [Abstract][Full Text] [Related]
13. [An evaluation of fibronectin and IgG in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Zhao HW; Lu CJ; Li ZH
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):93-5, 127. PubMed ID: 7994776
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
16. Laminin fragment P1 is increased in the lower respiratory tract of patients with diffuse interstitial lung diseases.
Pérez-Arellano JL; Pedraz MJ; Fuertes A; de la Cruz JL; González de Buitrago JM; Jiménez A
Chest; 1993 Oct; 104(4):1163-9. PubMed ID: 8404185
[TBL] [Abstract][Full Text] [Related]
17. Albumin is not suitable as a marker of bronchoalveolar lavage dilution in interstitial lung disease.
Ward C; Fenwick J; Booth H; Walters EH
Eur Respir J; 1997 Sep; 10(9):2029-33. PubMed ID: 9311497
[TBL] [Abstract][Full Text] [Related]
18. sTREM-1 in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis, effect of smoking and inflammation.
Suchankova M; Bucova M; E T; Demian J; Majer I; Novosadova H; Tedlova E; Durmanova V; Paulovicova E
Bratisl Lek Listy; 2013; 114(12):702-7. PubMed ID: 24329508
[TBL] [Abstract][Full Text] [Related]
19. Protein C anticoagulant system in patients with interstitial lung disease.
Kobayashi H; Gabazza EC; Taguchi O; Wada H; Takeya H; Nishioka J; Yasui H; Kobayashi T; Hataji O; Suzuki K; Adachi Y
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1850-4. PubMed ID: 9620917
[TBL] [Abstract][Full Text] [Related]
20. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
Front Immunol; 2020; 11():562564. PubMed ID: 33101280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
